Briefing Memo: Risks Of The Trans-Pacific Free Trade Agreement For Access To Medicines – Analysis Of The Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition Briefing Memo: Risks Of The Trans-Pacific Free Trade Agreement For Access To Medicines – Analysis Of The Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition – I-MAK

Briefing Memo: Risks Of The Trans-Pacific Free Trade Agreement For Access To Medicines – Analysis Of The Leaked U.S. Paper Eliminating Patent Pre-Grant Opposition

18 Jul 2011
View Resource

A leaked U.S. paper recently circulated to countries negotiating the TransPacific Partnership Agreement (TPPA) outlines the U.S. argument for eliminating “pre-grant opposition,” an important tool for preventing patent applicants from gaining patent monopolies based on weak or erroneous information, for improving the quality and efficiency of patent office examinations, and for safeguarding access to medicines.

Partner with us now to build
a more just and equitable
medicine system for all.